Cerebral amyloid angiopathy-related inflammation (CAA-I) is a rare variant of cerebral amyloid angiopathy (CAA). Its precise pathophysiology remains uncertain and we currently have limited evidence on which immunosuppressive agents are the most effective in its treatment. The disease course of CAA-I disorders can vary from an isolated clinical event to recurrent episodes. We present a case of biopsy-confirmed CAA-I that gives insight into its potential relapsing nature and the challenges of its long-term management.
CITATION STYLE
Salam, S., Anandarajah, M., Al-Bachari, S., Pal, P., Sussman, J., & Hamdalla, H. (2017). Relapsing cerebral amyloid angiopathy-related inflammation: The wax and the wane. Practical Neurology, 17(5), 392–395. https://doi.org/10.1136/practneurol-2017-001599
Mendeley helps you to discover research relevant for your work.